Redcliffe Labs, a diagnostics network, has announced the appointment of Rohit Jalan as its new Chief Investment Officer (CIO).
With over two decades of experience across investment banking, M&A, corporate development, and having been involved in 10+ successful public listings, Rohit brings a sharp strategic lens and deep financial acumen to the leadership team. His successful leadership as the Chief Business Officer- Inorganic, where he led Redcliffe’s Series C fundraise and executed multiple high-impact acquisitions across India, instils confidence in his ability to steer Redcliffe’s growth.
In this critical leadership role, Rohit will be responsible for driving Redcliffe’s capital strategy, leading inorganic growth initiatives, and laying the groundwork for the company’s IPO readiness.
As CIO, Rohit will steer strategic M&A, oversee pre-IPO fundraising, manage investor relations, and help shape the company’s public market narrative.
Aditya Kandoi, CEO and Founder, Redcliffe Labs, said, “Rohit has been a key force behind our strategic growth journey, especially in scaling Redcliffe through well-timed acquisitions and capital partnerships. His elevation to CIO is a crucial progression as we prepare for our next chapter, one that demands sharper capital stewardship, market readiness, and long-term value creation. His leadership will be instrumental in aligning Redcliffe’s growth ambitions with investor trust and sustained performance.”
Rohit Jalan said, “Over the past few years at Redcliffe, I’ve had the opportunity to lead some of our most transformative milestones, from driving strategic acquisitions to securing key funding rounds. Stepping into the role of CIO at such a crucial juncture is both exciting and humbling. As we prepare for the next phase of growth, my focus will be on scaling our capital strategy, deepening investor relationships, and unlocking long-term value for all stakeholders.”
